Article Information
History
- October 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tom M. Quinn#,1,2,
- Erin E. Gaughan#,1,2,
- Annya Bruce1,
- Jean Antonelli1,
- Richard O’Connor1,
- Feng Li1,
- Sarah McNamara1,
- Oliver Koch3,
- Claire MacIntosh3,
- David Dockrell1,3,
- Timothy Walsh1,2,
- Kevin G. Blyth4,
- Colin Church5,
- Jürgen Schwarze1,
- Cecilia Boz1,
- Asta Valanciute1,
- Matthew Burgess1,
- Philip Emanuel1,
- Bethany Mills1,
- Giulia Rinaldi1,
- Gareth Hardisty1,
- Ross Mills1,
- Emily Findlay1,
- Sunny Jabbal2,
- Andrew Duncan3,
- Sinéad Plant3,
- Adam D. L. Marshall1,2,
- Irene Young1,
- Kay Russell1,
- Emma Scholefield1,
- Alastair F. Nimmo2,
- Islom B. Nazarov6,7,
- Grant C. Churchill7,
- James S.O. McCullagh9,
- Kourosh H. Ebrahimi13,
- Colin Ferrett8,
- Kate Templeton2,
- Steve Rannard10,
- Andrew Owen10,
- Anne Moore1,
- Keith Finlayson1,
- Manu Shankar-Hari1,
- John Norrie11,
- Richard A. Parker11,
- Ahsan R. Akram1,2,
- Daniel C. Anthony7,
- James W. Dear2,12,
- Nik Hirani1,2 and
- Kevin Dhaliwal*,1,2
- 1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
- 2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
- 3Regional Infectious Disease Unit, NHS Lothian
- 4Institute of Cancer Sciences, University of Glasgow
- 5Department of Respiratory Medicine, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board, Glasgow, UK
- 6Latus Therapeutics, Oxford, UK
- 7Department of Pharmacology, University of Oxford, Oxford, UK
- 8Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
- 9Department of Chemistry, University of Oxford, Oxford, UK
- 10Centre of Excellence for Long-acting Therapeutics, Materials Innovation Factory & Department of Pharmacology and Therapeutics, University of Liverpool
- 11Edinburgh Clinical Trials Unit (ECTU), Usher Institute, University of Edinburgh, Edinburgh, UK
- 12Centre for Cardiovascular Science, Queen’s Medical Research Institute, Bioquarter, University of Edinburgh, Edinburgh, UK
- 13Institute of Pharmaceutical Science, King’s College London, UK
- ↵*Correspondence to Kev.Dhaliwal{at}ed.ac.uk
↵# contributed equally